How is the Alx Oncology Holdings Inc today?

The Alx Oncology Holdings Inc today is trading in the down by -1.89% at 0.52.

How has Alx Oncology Holdings Inc performed historically?

The Alx Oncology Holdings Inc is currently trading down -1.89% on an intraday basis in the past week the index rose 10.64%. The index has been down -50.00% in the past quarter and fell -94.09% in the past year. You can view this in the overview section.

What is Alx Oncology Holdings Inc Annual Net Profit?

Alx Oncology Holdings Inc Annual Net Profit rose 16.14% in the last year to $134.85 M. Its sector's average net profit growth for the last fiscal year was -12.66%.

What is Alx Oncology Holdings Inc Price to Earning Ratio?

Alx Oncology Holdings Inc Price to Earning Ratio is -0.21, which is negative.

What is Alx Oncology Holdings Inc Stock Price?

Alx Oncology Holdings Inc Stock Price fell 94.09% and underperformed its sector by 94.58% in the past year.

What is Alx Oncology Holdings Inc Quarterly Net profit?

Alx Oncology Holdings Inc Quarterly Net profit rose 13.57% YoY to $30.75 M. Its sector's average net profit growth YoY for the quarter was -18.37%.

What is Alx Oncology Holdings Inc Debt to Equity Ratio?

Alx Oncology Holdings Inc Debt to Equity Ratio of 0.09 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Alx Oncology Holdings Inc Return on Equity(ROE)?

Alx Oncology Holdings Inc Return on Equity(ROE) for the last financial year was -88.91%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Alx Oncology Holdings Inc Mutual Fund Holding?

Alx Oncology Holdings Inc Mutual Fund Holding increased by 1.2% in the last quarter to 23.33.

What is Alx Oncology Holdings Inc Interest Coverage Ratio?

Alx Oncology Holdings Inc Interest Coverage Ratio is -76.99, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is Alx Oncology Holdings Inc Institutional Holding?

Alx Oncology Holdings Inc Institutional Holding decreased by 9.73% in the last quarter to 65.25.

Alx Oncology Holdings Inc XNAS: ALXO

Alx Oncology Holdings Inc Live Share Price Today, Share Analysis and Chart

Name: Alx Oncology Holdings Inc: Is Infosys Ltd. worth buying?
Item: Alx Oncology Holdings Inc
Rating: 1.07158325
Author: Trendlyne DVM scores

about

ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, ...

0.52 -0.01 (-1.89%)

94.47% Fall from 52W High

202.0K XNAS Volume

XNAS 05 Jun, 2025 5:30 PM (EDT)

Board Meeting

The next board meeting for Alx Oncology Holdings Inc is on 12 Jun 2025 for the purpose of ALX Oncology Holdings Inc Annual General Meeting for 2025 See details

Not Eligible

Expensive Valuation

15.8 / 100

Technically Bearish

27.0 / 100

No estimates available

Alx Oncology Holdings Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Alx Oncology Holdings Inc Live Share Price Today, Share Analysis and Chart

ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, ...

94.47% Fall from 52W High

SWOT Analysis

Alx Oncology Holdings Inc Live Price Chart

Alx Oncology Holdings Inc FAQ

How is Alx Oncology Holdings Inc today?

Alx Oncology Holdings Inc today is trading in the red, and is down by -1.89% at 0.52.

How has Alx Oncology Holdings Inc performed historically?

Alx Oncology Holdings Inc is currently trading down -1.89% on an intraday basis. In the past week the stock rose 10.64%. stock has been down -50.00% in the past quarter and fell -94.09% in the past year. You can view this in the overview section.